SP

Sonia Poli

Dimerix Limited | Non-Executive Director
Dr Poli is a R&D professional with 25+ years' international experience in large and small pharmaceutical companies. She is an advisor for several early and late-stage drug development projects. She was formerly Executive Manager at AC Immune, a Nasdaq listed company, and Chief Scientific Officer at Sybilla biotech, Minoryx and Addex Therapeutics and she has previously worked within Swiss Stock Exchange listed company Hoffman la Roche.

Company and Role

Company
Title
Tenure
Since
DXB
DXB
Dimerix Limited
  • Non-Executive Director
11yrsJul 2015

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DXB
DXB
Dimerix Limited
12/12/25633,490N/A600,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DXB
DXB
Dimerix Limited
12/12/25
Issued
300,000$0.321$96,300Issue of options
DXB
DXB
Dimerix Limited
30/06/25
Expiry
47$0.574$27Options expired
DXB
DXB
Dimerix Limited
17/06/25
Buy
73,788$0.154$11,363Exercise of options
DXB
DXB
Dimerix Limited
17/06/25
Exercise
73,788$0.154$11,363Exercise of options
DXB
DXB
Dimerix Limited
21/10/24
Issued
300,000$0.367$110,148Employee Share Ownership Plan